Assessment of lipid metabolism‐disrupting effects of non‐phthalate plasticizer diisobutyl adipate through in silico and in vitro approaches

Abstract

AbstractDiisobutyl adipate (DIBA), as a novel non‐phthalate plasticizer, is widely used in various products. However, little effort has been made to investigate whether DIBA might have adverse effects on human health. In this study, we integrated an in silico and in vitro strategy to assess the impact of DIBA on cellular homeostasis. Since numerous plasticizers could activate peroxisome proliferator‐activated receptor γ (PPARγ) pathway to interrupt metabolism systems, we first utilized molecular docking to analyze interaction between DIBA and PPARγ. Results indicated that DIBA had strong affinity with the ligand‐binding domain of PPARγ (PPARγ‐LBD) at Histidine 499. Afterwards, we used cellular models to investigate in vitro effects of DIBA. Results demonstrated that DIBA exposure increased intracellular lipid content in murine and human hepatocytes, and altered transcriptional expression of genes related to PPARγ signaling and lipid metabolism pathways. At last, target genes regulated by DIBA were predicted and enriched for Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. Protein–protein interaction (PPI) network and transcriptional factors (TFs)‐genes network were established accordingly. Target genes were enriched in Phospholipase D signaling pathway, phosphatidylinositol 3‐kinase/protein kinase B (PI3K/Akt) and Epidermal growth factor receptor (EGFR) signaling pathway which were related to lipid metabolism. These findings suggested that DIBA exposure might disturb intracellular lipid metabolism homeostasis via targeting PPARγ. This study also demonstrated that this integrated in silico and in vitro methodology could be utilized as a high throughput, cost‐saving and effective tool to assess the potential risk of various environmental chemicals on human health.